GSK PLC (GS71.DE) Stock Income Statement
FRA:GS71 • GB00BN7SWP63
Current stock price
24.49 EUR
-0.65 (-2.59%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 32.67B | 31.38B | 30.33B | 29.32B | 24.70B | |||
| Minority Interest Expense | -573.00M | -376.00M | -380.00M | -665.00M | -711.00M | |||
| Cost Of Goods | 8.80B | 8.76B | 8.36B | 8.47B | 8.01B | |||
| Gross Profit | 23.86B | 22.62B | 21.96B | 20.86B | 16.69B | |||
| Operating Expenses | 14.27B | 14.40B | 13.64B | 12.46B | 10.94B | |||
| Research and Development | 6.55B | 6.01B | 5.75B | 5.06B | 4.53B | |||
| Selling, General, and Administrative Expenses | 8.94B | 8.96B | 9.01B | 8.13B | 6.75B | |||
| Operating Income | 9.60B | 8.22B | 8.32B | 8.39B | 5.75B | |||
| Interest Income/Expense | -674.00M | -2.54B | -1.29B | -1.44B | -2.36B | |||
| Other Income/Expense | -369.00M | 218.00M | -48.00M | -799.00M | 561.00M | |||
| Non Recurring Items | -1.15B | -2.43B | -914.00M | -529.00M | -355.00M | |||
| Income Before Taxes | 7.40B | 3.48B | 6.06B | 5.63B | 3.60B | |||
| Income Tax | 1.11B | 526.00M | 756.00M | 707.00M | 83.00M | |||
| Net Income | 5.72B | 2.58B | 4.93B | 14.96B | 4.38B | |||
| EBITDA | 11.91B | 10.78B | 10.62B | 10.54B | 8.13B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 1.39 | 0.62 | 1.20 | 3.66 | 1.08 | |||
| Non GAAP EPS | 1.72 | 1.59 | 1.55 | 1.48 | 1.42 | |||
| Statistics | ||||||||
| Gross Profit Margin | 73.05% | 72.10% | 72.42% | 71.13% | 67.58% | |||
| Profit Margin | 17.50% | 8.21% | 16.25% | 51.00% | 17.76% | |||
| Operating Profit Margin | 29.38% | 26.21% | 27.44% | 28.63% | 23.28% | |||
All data in GBP